Drug Trial Radar · NCT03878446
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
62
Actual
Start
Jul 4, 2019
Primary completion
May 5, 2021
Study completion Dec 23, 2026
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Mar 18, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study compares 2 medicines used for the treatment of children who are born small and who stayed small: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Participants will either get somapacitan or Norditropin® - which treatment is decided by chance. Both participants and the study doctor will know which treatment the participants get. The study will last for 5 years. Participants will take either an injection once every week or once every day.
Conditions
- Short Stature Children Born Small for Gestational Age (SGA)
Interventions
SomapacitanDrug
Somapacitan injected under the skin once a week.
Norditropin®Drug
Norditropin® injected under the skin once a day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Height VelocityTime frame: Baseline (week 0); week 26
Locations
95 sites in 23 countries. Site status is shown where the registry gives one.
Univ of AL at Birmingham_BRM
Birmingham, Alabama
Children's Hosp Of Orange
Orange, California
St. Luke's Children's Endo
Boise, Idaho
Univ of Minnesota M.C.H.
Minneapolis, Minnesota
Children's Minnesota
Saint Paul, Minnesota
Goryeb Children's Hospital
Morristown, New Jersey
Rutgers-Rwjms
New Brunswick, New Jersey
NYU Langone Hospital-LI
Garden City, New York
NYU Langone Hospital-LI
Mineola, New York
Icahn Sch of Med-Mt Sinai Hosp
New York, New York
CCHMC_Cinc
Cincinnati, Ohio
Univ Oklahoma Sci Ctr OK City
Oklahoma City, Oklahoma
Cook Children's Hospital-Hematology-Oncology
Fort Worth, Texas
MultiCare Inst for Res & Innov
Tacoma, Washington
CHU Bab El Oued Pediatrics Dept
Algiers, Algeria
Endo and Diab Dept El Oued
Algiers, Algeria
endocrino-diabetology department, Hospital IBN BADIS.
Constantine, Algeria
Med. Univ. Graz -Klinische Abteilung f. Allgemeine Pädiatrie
Graz, Austria
LKH Salzburg- Univ. Klinik f. Kinder- und Jugendheilkunde
Salzburg, Austria
LKH St. Poelten, Kinder-und Jugendheilkunde
Sankt Pölten, Austria
Salzkammergut-Klinikum Vöcklabruck
Vöcklabruck, Austria
Kepler Universitätsklinikum GmbH - Med Campus IV (vorm.LFKK)
Linz, Upper Austria, Austria
Stollery Children's Hospital
Edmonton, Alberta, Canada
Rigshospitalet Klinik for Vækst og Reproduktion Afsnit 5064
Copenhagen Ø, Denmark
Tallinn Children's Hospital
Tallinn, Estonia
Tartu University Hospital Children's Clinic
Tartu, Estonia
Centre Hospitalier Universitaire D'Angers-2
Angers, France
AP-HP-HOPITAL DE BICETRE_Service d'Endocrinologie pédiatrique
Le Kremlin-Bicêtre, France
Assistance Publique Hopitaux de Marseille-Hopital de La Timone-2
Marseille, France
Hopital de La Timone
Marseille Cédex 05, France
Ap-Hp-Hopital Necker
Paris, France
Hôpital Necker
Paris, France
HOPITAL DES ENFANTS-HOPITAL PAULE DE VIGUIER - Pharmacie
Toulouse, France
Észak-Közép-budai Centrum, Szent János Kórház és Szakrendelő
Budapest, Hungary
Szegedi Tudományegyetem Gyermekgyógyászati Klinika
Szeged, Hungary
Amrita Institute Of Medical Sciences & Research Centre
Kochi, Kerala, India
Jehangir Clinical Development Centre
Pune, Maharashtra, India
All India Institute of Medical Sciences
New Dehli, New Delhi, India
CHI Crumlin Dept of Endocrinology
Dublin, Ireland
Rambam MC - Department of Pediatrics A
Haifa, Israel
Showing 40 of 95 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.